POLYGLYCERYL-4 CAPRATE Cas:160391-93-5

We are POLYGLYCERYL-4 CAPRATE CAS:160391-93-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


POLYGLYCERYL-4 CAPRATE

Chemical Name:POLYGLYCERYL-4 CAPRATE
CAS.NO:160391-93-5
Synonyms:POLYGLYCERYL-4 CAPRATE
 
Description:
Colour Colorless to light yellow
Appearance Viscous liquid
Value content, % ≥98
Acid value, mg KOH/g  ≤6.0
Saponification value, mg KOH/g    35-55
Iodine value, I2/100g ≤5.0
Heavy metal, mg/kg ≤2.0
 
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Use:Suitable for skin care products, bath oils, makeup removers, such as makeup removers, makeup removers, etc.
 
Our quaternary ammonium salt series products reach more than 200 kinds, and the product categories cover high-content quaternary ammonium salt (powder, crystal, paste), low-content quaternary ammonium salt (liquid, paste), special quaternary ammonium salt, and quaternary ammonium salt. Alkali, etc., and can provide customized services for related products.
 
Our main R&D directions are: oilfield chemicals and quaternary ammonium salt downstream products (such as emulsifiers for pesticides, disinfectants for aquatic products, surfactants with special requirements for daily chemicals, etc.) and new innovative structures Surfactant. Therefore, in addition to supplying conventional surfactant products, we can also customize various surfactant products with special requirements according to customer needs to meet the special needs of various industries for surfactants.



Market News:IBI321 was discovered through a collaboration between Innovent and Eli Lilly and Company and has been developed in China by Innovent. The IND for IBI321 has been approved by the NMPA in China, and clinical trials in China are actively being conducted. L-Glutamine, L-lysyl-L-valyl-L-isoleucyl-L-leucyl- manufacturer.Conducted by Innovent in China, the CIBI321A101 trial is a Phase 1a open-label, multi-center study of the safety, tolerability and primary efficacy of IBI321 in patients with advanced solid tumors. Phase 1a of the study will evaluate dosing of IBI321 in a variety of solid tumors (ClinicalTrials.gov, NCT04911894). 2-(4-Chloro-phenyl)-1-hydrazino-but-3-en-2-ol supplier.The Japanese drugmaker is injecting $126 million into its Thousand Oaks facility to boost manufacturing and support new product lines, Pacific Coast Business Times first reported. Takeda was joined by the city’s mayor, Claudia Bill-de la Peña, for a groundbreaking event on Thursday, July 22. N-{4′-[2-ethoxy-2-(5-propyl-[1,3,4]oxadiazol-2-yl)ethyl]biphenyl-3-ylmethyl}-N-methylbiphenyl-4-carboxylamide producer.

Related Products
Product Name
2-chloro-1-methoxypropane View Details
2-(4-Diethylamino-2-hydroxybenzoyl)benzoic acid View Details
2-(2-Chloroethoxy)ethanol View Details
3-Piperazinobenzisothiazole Hydrochloride manufacturer 1,5-Dibromopentane manufacturer 2,3,5,6-Tetrafluoro-4-(Methoxymethyl) benzyl alcohol manufacturer 3-hydroxyisovaleric acid manufacturer 2-Bromopyridine-4-carboxylic acid manufacturer